30-day average of 21 articles · scale −100 to +100
Across 21 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of MetLife news is Somewhat Bullish (+40)
on a scale from −100 to +100.
That is about the same as the previous 30 days (+44).
💸 The company returned approximately $1 billion to shareholders via buybacks and dividends in Q3.
🏦 Net income surged 187% year-over-year to $2.4 billion, or $3.67 per share.
🎯 MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets.
💼 CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy and execution discipline.
📉 Holding-company cash and liquid assets stood at $3.4 billion, within management's target range.
🚀 Broad-based operating momentum supports the case for resilient earnings across divisions.
📈 Bullish signals
📈MetLife reported record Q3 adjusted EPS of $2.85 excluding notable items, a 22% increase from the prior-year quarter and the highest in company history.
💰Revenue increased 12% to $14.1 billion with growth spanning all six business segments, demonstrating broad-based momentum.
📊Adjusted return on equity reached 19.6% excluding notable items, reflecting strong capital efficiency.
💸The company returned approximately $1 billion to shareholders through buybacks and dividends, signaling confidence in its financial position.
🏦Net income surged 187% year-over-year to $2.4 billion, driven by higher variable investment income and favorable underwriting.
🎯MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets, ensuring disciplined capital management.
💼CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy, citing stronger underwriting and volume growth as key drivers.
Article
MetLife Inc. reported record third-quarter adjusted earnings per share of $2.85, excluding notable items, representing a 22% increase from the prior-year quarter. This achievement marks the highest quarterly level in the company's history, driven by broad-based growth across all six business segments. Revenue increased by 12% to $14.1 billion, supported by higher variable investment income, volume growth, and favorable underwriting results.
The company reported net income of $2.4 billion, or $3.67 per share, which was up 187% year-over-year. Adjusted return on equity reached 19.6% excluding notable items, while MetLife confirmed it remains on track to meet its full-year targets for free cash flow and direct expense ratios. Holding-company cash and liquid assets stood at $3.4 billion at quarter-end, aligning with management's target range.
MetLife returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter, highlighting a continued focus on capital returns alongside reinvestment for growth. CEO Michel Khalaf emphasized that the results demonstrate the strength of the New Frontier strategy and the discipline of its execution, citing stronger underwriting and investment returns as key drivers.
The earnings release indicates broad operating momentum rather than growth concentrated in a single division, supporting the case for resilient earnings. MetLife stock traded at 92.45 euros on November 12, 2026, reflecting positive market sentiment following the announcement of these robust financial results and strategic confidence.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
MetLife Inc. reported record third-quarter adjusted earnings per share of $2.85, excluding notable items, representing a 22% increase from the prior-year quarter. This achievement marks the highest quarterly level in the company's history, driven by broad-based growth across all six business segments. Revenue increased by 12% to $14.1 billion, supported by higher variable investment income, volume growth, and favorable underwriting results.
The company reported net income of $2.4 billion, or $3.67 per share, which was up 187% year-over-year. Adjusted return on equity reached 19.6% excluding notable items, while MetLife confirmed it remains on track to meet its full-year targets for free cash flow and direct expense ratios. Holding-company cash and liquid assets stood at $3.4 billion at quarter-end, aligning with management's target range.
MetLife returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter, highlighting a continued focus on capital returns alongside reinvestment for growth. CEO Michel Khalaf emphasized that the results demonstrate the strength of the New Frontier strategy and the discipline of its execution, citing stronger underwriting and investment returns as key drivers.
The earnings release indicates broad operating momentum rather than growth concentrated in a single division, supporting the case for resilient earnings. MetLife stock traded at 92.45 euros on November 12, 2026, reflecting positive market sentiment following the announcement of these robust financial results and strategic confidence.
📈 MetLife Q3 adjusted EPS rose 22% to $2.85 excluding notable items.
💰 Revenue grew 12% to $14.1 billion across all six business segments.
📊 Adjusted return on equity hit 19.6%, surpassing analyst expectations.
💸 Company returned ~$1 billion to shareholders via buybacks and dividends.
🎯 MetLife remains on track for full-year free cash flow targets.
📈 MetLife reported record Q3 adjusted EPS of $2.85 excluding notable items, a 22% increase from the prior-year quarter.
💰 Revenue increased 12% to $14.1 billion with growth spanning all six business segments.
💸 The company returned approximately $1 billion to shareholders via buybacks and dividends in Q3.
🏦 Net income surged 187% year-over-year to $2.4 billion, or $3.67 per share.
🎯 MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets.
💼 CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy and execution discipline.
📉 Holding-company cash and liquid assets stood at $3.4 billion, within management's target range.
🚀 Broad-based operating momentum supports the case for resilient earnings across divisions.
Bullish Signals
Record Q3 EPS of $2.85, up 22% year-over-year.
Bullish Signals
MetLife reported record Q3 adjusted EPS of $2.85 excluding notable items, a 22% increase from the prior-year quarter and the highest in company history.
Revenue increased 12% to $14.1 billion with growth spanning all six business segments, demonstrating broad-based momentum.
Adjusted return on equity reached 19.6% excluding notable items, reflecting strong capital efficiency.
The company returned approximately $1 billion to shareholders through buybacks and dividends, signaling confidence in its financial position.
Net income surged 187% year-over-year to $2.4 billion, driven by higher variable investment income and favorable underwriting.
MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets, ensuring disciplined capital management.
CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy, citing stronger underwriting and volume growth as key drivers.
MetLife Inc. reported record adjusted earnings per share for the third quarter, reaching a company high of $2.85 excluding notable items, representing a 22% increase from the prior year. This achievement marks the highest quarterly level in the insurer's history and reflects strong performance across all six business segments.
Revenue growth was broad-based, with total premiums, fees, and other revenues rising 12% to $14.1 billion. Group Benefits contributed $523 million in adjusted earnings, while Retirement and Income Solutions generated $413 million. The company also highlighted continued expansion in international operations and asset management.
Financial metrics exceeded expectations, with adjusted return on equity reaching 19.6%, surpassing the full-year target range of 15% to 17%. MetLife returned approximately $1 billion to shareholders via dividends and share repurchases, while holding company cash and liquid assets remained within the target range at $3.4 billion.
CEO Michel Khalaf attributed the results to the New Frontier strategy, disciplined execution, solid underwriting, volume growth, and higher investment returns. Management reaffirmed confidence in meeting full-year targets for free-cash-flow ratio and direct expense ratio despite a $46 million charge related to an annual actuarial assumption review.
📈 MetLife Q3 adjusted EPS hit record $2.85, up 22%.
💰 Revenue grew 12% to $14.1B driven by underwriting and investments.
🏦 Adjusted ROE reached 19.6%, surpassing the 15-17% target range.
💸 MetLife returned ~$1B to shareholders via dividends and buybacks.
🚀 CEO Khalaf reaffirmed confidence in New Frontier strategy execution.
📈 MetLife achieved a record adjusted EPS of $2.85 for Q3, a 22% year-over-year increase.
💰 Total revenue grew 12% to $14.1 billion driven by underwriting and investment income.
🏦 Adjusted return on equity hit 19.6%, exceeding the full-year target range of 15-17%.
📉 Group Benefits segment delivered $523 million in adjusted earnings for the quarter.
👴 Retirement and Income Solutions generated $413 million in adjusted earnings.
💸 The company returned approximately $1 billion to shareholders through dividends and buybacks.
🏛️ Holding company cash and liquid assets stood at $3.4 billion, within management targets.
🚀 CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy execution.
⚖️ A $46 million charge related to actuarial assumption review was excluded from adjusted metrics.
📊 Adjusted premiums and fees excluding pension risk transfers rose 8% to $13.5 billion.
Bullish Signals
Record Q3 EPS of $2.85 achieved.
Revenue rose 12% across all segments.
Adjusted ROE hit 19.6%, above target.
Returned $1B to shareholders via buybacks.
Cash assets robust at $3.4 billion.
Risk Factors
Recorded $46M actuarial charge impacting adjusted EPS.
Adjusted EPS of $2.85 excludes notable items.
Bullish Signals
MetLife reported a record adjusted EPS of $2.85 for Q3, marking the highest quarterly level in company history.
Revenue increased across all six business segments, with total premiums and fees rising 12% to $14.1 billion.
Adjusted return on equity reached 19.6%, significantly above the full-year target range of 15% to 17%.
The company returned approximately $1 billion to shareholders via common-stock dividends and share repurchases.
Holding-company cash and liquid assets remained robust at $3.4 billion, within management's target range.
Management reaffirmed confidence in the New Frontier strategy and is on track to meet full-year free-cash-flow targets.
Risk Factors
The record adjusted EPS included a $46 million charge related to the annual actuarial assumption review.
Adjusted earnings per share of $2.85 excludes notable items, which investors must consider when comparing to reported net income of $3.67 per share.
MetLife Inc. reported record third-quarter adjusted earnings per share and broad revenue growth across all six business segments for the quarter ended September 30, 2026. Adjusted earnings rose 12 percent to $1.8 billion, while adjusted earnings per share excluding notable items increased 22 percent to $2.85. Premiums, fees, and other revenues grew 12 percent to $14.1 billion, driven by volume growth in underwriting and investment income.
Group Benefits adjusted earnings climbed 15 percent to $523 million, and MetLife Investment Management reported higher adjusted earnings alongside growth in Asia, Latin America, Europe, the Middle East, and Africa regions. Retirement and Income Solutions saw a reported decline of 6 percent but achieved a 12 percent increase in adjusted earnings excluding notable items, reaching $478 million. The company also returned approximately $1 billion to shareholders through stock repurchases and common stock dividends.
Separately, an Ontario Superior Court of Justice approved a $213.5 million Canadian dollar settlement on October 27 regarding legacy life insurance policies originally sold by MetLife agents in Canada. The agreement covers approximately 70,000 current and former policyholders and includes compensation and limits on selected policy charges. While Sun Life administers the policies and seeks recovery under an indemnity arrangement, this legal exposure keeps historical obligations in focus for investors.
The annual actuarial assumption review reduced adjusted earnings by $46 million, yet excluding total notable items, adjusted earnings reached $1.826 billion compared with $1.566 billion in the prior-year quarter. MetLife stock traded at 88.19 euros on November 7, 2026, as investors weigh strong operating performance against legacy-policy obligations. The results highlight momentum from core business segments while maintaining attention on regulatory and legal settlements.
📈 MetLife Q3 adjusted EPS rose 22% to $2.85.
💰 Total revenues increased 12% to $14.1 billion.
🌍 All international segments reported higher adjusted earnings.
⚖️ Ontario court approved $213.5M settlement for 70,000 policies.
📉 Actuarial review reduced quarterly adjusted earnings by $46M.
📈 MetLife reported record third-quarter adjusted earnings per share of $2.85 excluding notable items, a 22 percent increase year-over-year.
💰 Total premiums, fees, and other revenues rose 12 percent to $14.1 billion, with Group Benefits adjusted earnings up 15 percent to $523 million.
🌍 International segments including Asia, Latin America, Europe, the Middle East, and Africa all reported higher adjusted earnings in Q3 2026.
⚖️ An Ontario court approved a $213.5 million Canadian dollar settlement covering approximately 70,000 legacy policyholders originally sold by MetLife agents.
📉 The annual actuarial assumption review reduced adjusted earnings by $46 million for the quarter ended September 30.
💸 MetLife returned approximately $1 billion to shareholders through stock repurchases and common stock dividends during the quarter.
📊 Adjusted earnings excluding notable items reached $1.826 billion, up from $1.566 billion in the prior-year quarter.
Bullish Signals
EPS rose 22% to $2.85.
Revenue grew 12% to $14.1B.
Group Benefits earnings up 15%.
International operations all posted gains.
Returned $1B via buybacks/dividends.
Risk Factors
Court approved $213.5M settlement for legacy life insurance policies.
Actuarial review reduced Q3 adjusted earnings by $46M.
Retirement solutions earnings down 6% on reported basis.
Bullish Signals
MetLife reported record third-quarter adjusted earnings per share of $2.85 excluding notable items, representing a 22 percent year-over-year increase.
Premiums, fees, and other revenues grew 12 percent to $14.1 billion, demonstrating strong top-line momentum across all six business segments.
Group Benefits adjusted earnings rose 15 percent to $523 million, highlighting robust performance in the core group insurance business.
International operations including Asia, Latin America, Europe, the Middle East, and Africa all reported higher adjusted earnings during the quarter.
MetLife returned approximately $1 billion to shareholders through stock repurchases and common stock dividends, signaling confidence in capital allocation.
Retirement and Income Solutions achieved a 12 percent increase in adjusted earnings excluding notable items, reaching $478 million despite reported headwinds.
Risk Factors
An Ontario Superior Court of Justice approved a $213.5 million Canadian dollar settlement related to legacy life insurance policies originally sold by MetLife agents.
The annual actuarial assumption review reduced adjusted earnings by $46 million for the third quarter ended September 30, 2026.
Retirement and Income Solutions reported adjusted earnings of $413 million, which was down 6 percent on a reported basis compared to the prior year.
Company updateEarnings reportAI-generated analysis
MetLife reported a strongly positive third-quarter earnings call, delivering record adjusted earnings of $1.8 billion or $2.78 per share. Excluding notable items, adjusted EPS rose 22% year over year to $2.85, while year-to-date growth also reached 22%. The company achieved an adjusted return on equity of 19.6%, comfortably exceeding its annual target range of 15% to 17%, and management indicated the business is well-positioned to exceed its full-year ROE goal.
Top-line growth was reported across every operating segment, reducing reliance on any single business line. Group Benefits led underwriting performance with adjusted earnings rising 14% driven by favorable mortality trends, while RIS and Asia benefited from investments. Latin America and EMEA led revenue growth, with EMEA earnings climbing 30% and Latin America PFOs increasing 22%. The company also reported strong capital generation, deploying $3.8 billion in 2025 and generating $2.8 billion of value of new business.
MetLife demonstrated disciplined expense management with a direct expense ratio of 11.9% for the quarter, below its 12.1% target, aided by technology and artificial intelligence productivity gains. The company repurchased $650 million of shares in the third quarter and another $265 million in October, bringing year-to-date capital returned to about $3.5 billion. Management highlighted substantial financial flexibility with a Japan solvency ratio of 192% and maintained key targets for full-year performance despite manageable headwinds in specific regions.
Looking ahead, MetLife expects the full-year direct expense ratio to beat 11.1% and adjusted ROE to exceed its target range. The company guided fourth-quarter variable investment income between $400 million company-wide and $100 million to $120 million for Retirement and Income Solutions. While management noted watch points such as Asia sales declines and Latin American encaje pressure, the overall message was confident with a focus on organic growth and strict financial standards for any potential acquisitions.
📈 MetLife reported record quarterly adjusted earnings of $1.8 billion.
📊 Adjusted return on equity reached 19.6%, exceeding the 15% to 17% target.
💰 Company deployed $3.8 billion capital and generated $2.8 billion new business value.
🔄 MetLife repurchased $3.5 billion in shares year-to-date.
⚠️ Asia sales fell 6% while Latin America faced a $30 million headwind.
📈 MetLife delivered record quarterly adjusted earnings of $1.8 billion or $2.78 per share, with adjusted EPS rising 22% year over year to $2.85.
📊 Adjusted return on equity reached 19.6%, significantly above the company's 15% to 17% annual target range.
💰 The company deployed $3.8 billion of capital in 2025 and generated $2.8 billion of value of new business with a 19% internal rate of return.
📉 Direct expense ratio was 11.9% for the quarter, beating the 12.1% target thanks to technology and AI productivity gains.
🔄 MetLife repurchased $650 million of shares in Q3 and an additional $265 million in October, totaling about $3.5 billion returned year-to-date.
🌍 Group Benefits adjusted earnings rose 14% driven by favorable underwriting and improving working-age mortality ratios.
📈 EMEA adjusted earnings climbed 30% to $114 million while Latin America PFOs increased 22% led by Mexico and Chile.
💼 MetLife Investment Management assets under management reached $723 billion with adjusted earnings increasing 9% in the quarter.
🔮 Management expects full-year direct expense ratio to beat 11.1% and adjusted ROE to exceed the 15% to 17% target range.
⚠️ Asia quarterly sales fell 6% in constant currency, though less favorable underwriting partly offset investment gains.
🌎 Latin America earnings faced a $30 million headwind from negative encaje returns, creating an estimated year-over-year impact.
🤝 MetLife launched a multi-market embedded-insurance partnership with Revolut and plans to apply digital capabilities to Asia.
🏦 Japan's economic solvency ratio was 192%, reinforcing management's view of substantial financial flexibility across major markets.
🛡️ The company reported $4.1 billion in hyperscaler and data-center exposure, representing less than 1% of the general account with no delinquencies.
📉 Disability segment experienced slight increases in claim severity and submissions, requiring monitoring of macroeconomic trends.
Bullish Signals
Adjusted earnings rose 22% YoY to $2.85 per share.
Risk Factors
Asia sales fell 6% vs strong comparison due to underwriting.
Bullish Signals
MetLife reported record quarterly adjusted earnings of $1.8 billion or $2.78 per share, with adjusted EPS rising 22% year over year to $2.85.
Adjusted return on equity reached 19.6%, comfortably exceeding the company's 15% to 17% annual target range and positioning it to exceed full-year goals.
Top-line growth was reported across every operating segment, reducing reliance on any single business line while Group Benefits led underwriting performance.
The direct expense ratio was 11.9% for the quarter, below the 12.1% target, with technology and AI productivity gains offsetting integration costs.
MetLife repurchased $650 million of shares in Q3 and another $265 million in October, bringing year-to-date capital returned to about $3.5 billion.
Group Benefits adjusted earnings rose 14% driven by favorable underwriting and improving working-age mortality ratios, with the mortality ratio improving to 79.5%.
EMEA adjusted earnings climbed 30% to $114 million while Latin America PFOs increased 22%, demonstrating broad-based international growth.
MetLife Investment Management assets under management reached $723 billion with adjusted earnings increasing 9% in the quarter and margins expanding sequentially.
The company generated $2.8 billion of value of new business producing a 19% internal rate of return for the third consecutive year.
Japan's economic solvency ratio was 192%, well above the 170% to 190% range, reinforcing management's view of substantial financial flexibility.
Risk Factors
Asia quarterly sales fell 6% in constant currency against a strong comparison, with less favorable underwriting partly offsetting investment gains.
Latin America earnings increased only 3% in reported terms but fell 5% in constant currency due to a negative 3% encaje return creating a $30 million headwind.
Disability segment experienced slight increases in claim severity, higher submissions, and more mental and nervous claims requiring monitoring of macroeconomic trends.
MIM assets under management fell $25 billion sequentially primarily because higher rates reduced the value of public fixed-income holdings.
U.S. pension risk transfer activity was lighter year to date, though management characterized the slowdown as timing-related rather than structural.
MetLife (MET) reported third-quarter revenue of $19.91 billion, marking an 11.2% increase year-over-year. Earnings per share reached $2.85, surpassing the consensus estimate of $2.71 by 5.17%, even though headline revenue slightly missed analyst expectations at $20.11 billion.
The company's asset management segments showed mixed performance against estimates. Institutional Client AUM stood at $307.96 billion versus a $326.37 billion average estimate, while Total AUM was $723.44 billion compared to an expected $753.76 billion. MetLife Investment Management specifically reported $415.48 billion in assets under management against a $427.39 billion consensus.
Key revenue drivers included premiums of $11.82 billion, which grew 12% year-over-year but fell short of the $12.11 billion analyst average. Net investment income totaled $6.2 billion, representing a modest 1.8% increase over the prior year and exceeding the estimated $5.89 billion. Policy fees for universal life and investment-type products reached $1.39 billion, up 11.1% from the previous year.
Regional performance highlighted significant growth in specific segments despite some misses in others. Retirement & Income Solutions premiums surged 74.5% to $1.82 billion, though this was below the $2 billion analyst projection. Latin America and EMEA regions contributed adjusted revenues of $425 million and $73 million respectively, both exceeding their respective consensus estimates.
📈 MetLife Q3 revenue rose 11.2% YoY to $19.91 billion.
💰 EPS of $2.85 beat estimates by 5.17%.
💵 Premiums revenue grew 12% YoY to $11.82 billion.
🚀 Retirement premiums surged 74.5% to $1.82 billion.
📊 Net investment income exceeded estimates at $6.2 billion.
📈 MetLife reported Q3 revenue of $19.91 billion, an 11.2% year-over-year increase.
💰 EPS came in at $2.85, beating the Wall Street consensus estimate of $2.71 by 5.17%.
📉 Total assets under management reached $723.44 billion, slightly below the $753.76 billion analyst average.
🏦 Institutional Client AUM stood at $307.96 billion versus a consensus of $326.37 billion.
💵 Premiums revenue hit $11.82 billion, reflecting a 12% year-over-year growth.
📊 Net investment income was $6.2 billion, exceeding the estimated $5.89 billion.
🌎 MetLife Investment Management reported $415.48 billion in AUM against a $427.39 billion estimate.
🚀 Retirement & Income Solutions premiums jumped 74.5% to $1.82 billion.
📉 Universal life and investment-type product policy fees reached $1.39 billion, up 11.1%.
Bullish Signals
EPS beat estimates at $2.85 vs $2.71 consensus.
Risk Factors
Revenue missed consensus by 1.02% at $19.91B.
Total AUM fell short of analyst average.
Institutional Client AUM was below estimates.
Bullish Signals
MetLife beat EPS estimates with earnings of $2.85 versus the consensus of $2.71.
Premiums revenue grew 12% year-over-year to reach $11.82 billion.
Net investment income increased 1.8% to $6.2 billion, surpassing analyst expectations.
Retirement & Income Solutions premiums surged 74.5% to $1.82 billion.
Latin America adjusted revenue for universal life and investment-type products grew 12.7% to $425 million.
EMEA net investment income rose 9% year-over-year to $73 million.
Risk Factors
Headline revenue of $19.91 billion missed the Zacks Consensus Estimate of $20.11 billion by 1.02%.
Total assets under management of $723.44 billion fell short of the $753.76 billion analyst average.
Institutional Client AUM of $307.96 billion was below the three-analyst average estimate of $326.37 billion.
MetLife reported third-quarter 2026 results that exceeded Wall Street expectations for total revenue, which rose 14.6% year-over-year to $20.52 billion. This performance beat analyst consensus estimates by 3.5%, driven by strong overall top-line growth despite a miss in core underwriting metrics.
The company's non-GAAP profit per share of $2.78 aligned with consensus estimates, while book value per share grew significantly to $59.41, reflecting a 35.6% year-over-year increase. However, net premiums earned fell flat year-over-year at $11.82 billion, missing analyst expectations of $12.32 billion by 4.1%, indicating a divergence between total revenue growth and core insurance business expansion.
MetLife's financial performance highlights a mixed quarter where investment income and fee services likely offset weaker premium growth to drive the revenue beat. The company's shares remained flat at $103.01 immediately following the release, suggesting investors weighed the strong revenue surprise against the underwriting miss and neutral earnings guidance.
Analysts maintain a forward-looking consensus for MetLife's book value per share to grow by 10.3% over the next 12 months to reach $59.75. While the five-year compounded annual growth rate for revenue has been sluggish at 3.4%, recent two-year trends show acceleration, with annualized revenue growth reaching 7.6% as the company navigates changing interest rate environments.
📈 MetLife Q3 revenue rose 14.6% to $20.52B, beating estimates by 3.5%.
💰 Non-GAAP profit hit $2.78/share, matching analyst consensus expectations.
📉 Net premiums earned flat at $11.82B, missing estimates by 4.1%.
📚 Book value per share surged 35.6% YoY to $59.41.
🏦 Revenue beat driven by investment income as core insurance premiums stagnated.
📈 MetLife reported Q3 2026 revenue of $20.52 billion, a 14.6% year-over-year increase that beat Wall Street consensus estimates by 3.5%.
💰 The company posted non-GAAP profit of $2.78 per share, which was in line with analysts' consensus expectations.
📉 Net premiums earned totaled $11.82 billion, representing a flat year-over-year performance that missed analyst estimates of $12.32 billion by 4.1%.
📚 Book value per share reached $59.41, marking a substantial 35.6% year-over-year growth despite a minor miss against consensus estimates of $59.75.
🏦 MetLife's revenue beat was driven by investment income and fees, as core insurance premiums failed to grow organically during the quarter.
📊 The company's shares traded flat at $103.01 immediately after the earnings release, reflecting a neutral market reaction to mixed results.
🔮 Analysts project MetLife's book value per share will grow by 10.3% over the next 12 months to reach $59.75.
📈 Recent two-year annualized revenue growth of 7.6% suggests an acceleration from the company's sluggish five-year compounded growth rate of 3.4%.
Bullish Signals
Q3 2026 revenue hit $20.52B, beating estimates by 3.5%.
Non-GAAP EPS of $2.78 matched analyst consensus expectations.
Book value per share rose 35.6% year-over-year to $59.41.
Two-year revenue growth reached 7.6%, reversing a five-year slump.
Risk Factors
Net premiums fell 4.1% to $11.82B, missing consensus.
Five-year revenue growth is sluggish at 3.4%.
Bullish Signals
MetLife reported Q3 2026 revenue of $20.52 billion, a 14.6% year-over-year increase that significantly beat Wall Street consensus estimates by 3.5%.
The company achieved a non-GAAP profit per share of $2.78, which aligned perfectly with analysts' consensus expectations, demonstrating earnings stability.
Book value per share surged to $59.41, representing a robust 35.6% year-over-year growth that reflects strong long-term capital accumulation for shareholders.
MetLife's recent two-year annualized revenue growth of 7.6% indicates a positive trend reversal from its sluggish five-year compounded growth rate.
Risk Factors
Net premiums earned declined year-over-year to $11.82 billion, missing analyst consensus estimates of $12.32 billion by 4.1% and signaling weakness in the core insurance business.
The company's five-year compounded annual revenue growth rate remains sluggish at 3.4%, falling short of the broader insurance sector benchmark.
MetLife Inc. faces renewed investor scrutiny following the Ontario Superior Court of Justice's approval of a C$213.5 million settlement regarding legacy Canadian insurance policies sold between 1985 and 1998. The agreement, which addresses policies originally administered by Sun Life after its acquisition of Clarica (which bought MetLife's Canadian operations in 1998), limits future charges and administration fees for approximately 70,000 eligible current and former policyholders.
Under the terms of the settlement, Flexiplus policyholders will see their cost-of-insurance and administration fee increases permanently frozen, while holders of pre-1992 Universal Plus policies will receive compensation for charges exceeding specific premium limits. Although Sun Life has denied wrongdoing and plans to seek recovery from MetLife under an indemnity provision provided by the insurer, this arrangement does not establish a new immediate earnings impact for MetLife but maintains potential financial exposure linked to its former Canadian business.
The company is scheduled to release its third-quarter 2026 results after the US market close on November 4, followed by an earnings call on November 5. This upcoming report will provide investors with a critical opportunity to assess MetLife's operating performance alongside the renewed focus on these historic policy liabilities and the implications of the approved settlement.
👥 70,000 policyholders eligible for benefits and fee freezes.
💰 Flexiplus fees frozen; Universal Plus charges capped.
⚠️ Sun Life seeks recovery from MetLife under indemnity.
📅 Q3 2026 results released November 4 after US close.
🏛️ The Ontario Superior Court of Justice approved a C$213.5 million settlement on October 27, 2026, regarding legacy MetLife policies sold between 1985 and 1998.
👥 Approximately 70,000 current and former policyholders are eligible for benefits under the arrangement covering Flexiplus and pre-1992 Universal Plus policies.
💰 Eligible Flexiplus policyholders will receive compensation with future cost-of-insurance and administration fees permanently frozen.
📉 Pre-1992 Universal Plus holders will be compensated for charges above specified premium limits, while future cost-of-insurance charges are capped for eligible current holders.
⚖️ Sun Life has denied wrongdoing but plans to seek recovery from MetLife under an indemnity provision, keeping potential financial exposure linked to the former Canadian business relevant for investors.
📅 MetLife is scheduled to release third-quarter 2026 results after the US market close on November 4, with an earnings call following on November 5.
📊 The upcoming Q3 report will allow investors to assess operating performance alongside the renewed focus on historic policy liabilities and the settlement's implications.
Risk Factors
C$213.5M settlement exposes legacy Canadian business financial risk.
Risk Factors
MetLife faces renewed investor scrutiny and potential financial exposure linked to its former Canadian business following a C$213.5 million court-approved settlement.
Although Sun Life plans to seek recovery from MetLife under an indemnity provision, the arrangement maintains ongoing relevance for investors regarding historic policy liabilities.
The settlement covers policies sold between 1985 and 1998, highlighting long-term legacy risks associated with MetLife's historical Canadian operations.
On August 17, 2026, MetLife, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission to announce dividend declarations for four of its preferred stock series. The filing details specific quarterly or semi-annual dividend rates and liquidation preferences for Series A, D, E, and F, providing precise financial terms for these capital instruments.
The company declared a quarterly dividend of $0.31471411 per share on its Floating Rate Non-Cumulative Preferred Stock, Series A, which carries a $25 liquidation preference. Additionally, a semi-annual dividend of $29.375 per share was announced for the 5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D, with a $1,000 liquidation preference.
MetLife also declared dividends for two high-value series: Series E received a quarterly dividend of $351.5625 per share on its 5.625% Non-Cumulative Preferred Stock with a $25,000 liquidation preference, while Series F was assigned a quarterly dividend of $296.875 per share on its 4.75% Non-Cumulative Preferred Stock, also with a $25,000 liquidation preference.
The Form 8-K was signed by Timothy J. Ring, Senior Vice President and Secretary of MetLife, Inc., confirming the declarations under Item 8.01 (Other Events). The filing reiterates that MetLife's common stock trades on the NYSE under ticker MET with a par value of $0.01 per share.
📅 MetLife filed SEC Form 8-K on August 17, 2026 for preferred stock dividends.
💰 Series A received $0.3147 quarterly dividend with $25 liquidation preference.
📉 Series D declared $29.375 semi-annual dividend with $1,000 liquidation preference.
💵 Series E granted $351.5625 quarterly dividend with $25,000 liquidation preference.
📊 Series F declared $296.875 quarterly dividend with $25,000 liquidation preference.
📅 On August 17, 2026, MetLife filed an SEC Form 8-K to declare dividends for four distinct preferred stock series.
💰 Series A received a quarterly dividend of $0.31471411 per share on its Floating Rate Non-Cumulative Preferred Stock with a $25 liquidation preference.
📉 Series D declared a semi-annual dividend of $29.375 per share on the 5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock carrying a $1,000 liquidation preference.
💵 Series E was granted a quarterly dividend of $351.5625 per share on its 5.625% Non-Cumulative Preferred Stock with a $25,000 liquidation preference.
📊 Series F declared a quarterly dividend of $296.875 per share on the 4.75% Non-Cumulative Preferred Stock with a $25,000 liquidation preference.
🏢 The filings specify that MetLife's common stock is traded on the NYSE under ticker MET with a par value of $0.01 per share.
✍️ The Form 8-K was signed by Timothy J. Ring, Senior Vice President and Secretary of MetLife, Inc.
Bullish Signals
MetLife declared dividends on four preferred stock series on August 17, 2026.
Specific dividend amounts indicate stable cash flow supporting fixed-income investors.
Bullish Signals
MetLife successfully declared dividends for four series of preferred stock (A, D, E, and F) on August 17, 2026, demonstrating the company's ability to meet its capital distribution obligations.
The declaration of specific dividend amounts, such as $351.5625 per share for Series E and $296.875 per share for Series F, indicates stable cash flow generation sufficient to support fixed-income investors.
MetLife Inc. faces renewed investor scrutiny regarding legacy policy liabilities following a court-approved settlement in Ontario, Canada. The Ontario Superior Court of Justice approved a national class action settlement valued at $213.5 million involving approximately 70,000 current and former policyholders whose life insurance policies were originally sold by MetLife agents.
The legal proceedings center on historical contracts rather than new product launches or underwriting changes. The case involves policies that were later administered by Sun Life after its acquisition of Clarica Life Insurance Co., with MetLife having provided an indemnity covering these specific legacy obligations to the insurer.
MetLife is scheduled to release its third-quarter 2026 financial results after the U.S. market closes on Wednesday, November 4. The company will hold its earnings conference call on Thursday, November 5, from 9:00 to 10:00 a.m. Eastern time, where management is expected to discuss insurance trends and the financial implications of these legacy policy matters.
The stock traded at 89.62 euros as of October 31, 2026. Investors are closely watching how the company manages this historical liability alongside its upcoming quarterly performance update, which will serve as a key checkpoint for the insurer's operating health.
⚖️ Ontario court approved $213.5M settlement for 70,000 legacy policyholders.
🔄 Sun Life administers policies with MetLife providing indemnity coverage.
📅 Q3 2026 results released after market close on November 4.
📞 Earnings call scheduled Thursday, November 5, 9:00-10:00 a.m. ET.
📈 Stock traded at 89.62 euros on October 31, 2026.
🏛️ An Ontario court approved a $213.5 million settlement regarding legacy life insurance policies originally sold by MetLife agents.
👥 The legal case involves approximately 70,000 current and former policyholders affected by the historical contracts.
🔄 Policies were later administered by Sun Life after its acquisition of Clarica Life Insurance Co., with MetLife providing an indemnity.
📅 MetLife will release third-quarter 2026 financial results after market close on Wednesday, November 4.
📞 The earnings conference call is scheduled for Thursday, November 5, from 9:00 to 10:00 a.m. Eastern time.
💰 Investors are focusing on management's discussion of insurance trends and the financial impact of legacy liabilities.
📈 MetLife stock traded at 89.62 euros on October 31, 2026.
Risk Factors
$213.5M liability from Ontario settlement for legacy policies.
Case covers ~70,000 policyholders originally sold by agents.
Investors scrutinize financial impact before Q3 earnings.
Risk Factors
MetLife faces a $213.5 million liability from an Ontario court-approved settlement regarding legacy policies.
The legal case involves approximately 70,000 policyholders whose contracts were originally sold by MetLife agents.
Investors are scrutinizing the financial implications of these historical liabilities during the upcoming Q3 earnings call.
MetLife Inc. faces a significant legacy liability as the Ontario Superior Court of Justice approved a CAD 213.5 million settlement regarding life insurance policies sold by its agents in Canada between 1985 and 1998. The agreement addresses concerns over cost-of-insurance charges and administration fees for approximately 70,000 current and former policyholders, specifically targeting Flexiplus and Universal Plus products issued prior to 1992.
Although Sun Life Assurance Company of Canada administers the policies and denied wrongdoing, the settlement highlights MetLife's exposure to its historic Canadian business following Clarica's acquisition in 1998. The ruling freezes certain charges for current holders and caps future cost-of-insurance fees for qualifying policyholders, directly impacting the insurer's obligations toward a specific legacy portfolio.
Analysts note that while the headline settlement amount is CAD 213.5 million, the immediate investor focus remains on how indemnity arrangements and potential recovery claims from Sun Life affect MetLife's overall exposure to this legacy book rather than altering the performance of its current operating businesses. The case underscores the ongoing financial implications of historical sales practices for the insurer.
⚖️ Canadian court approved CAD 213.5M settlement for MetLife legacy policies.
👥 Settlement covers ~70,000 policyholders issued between 1985 and 1998.
💰 Flexiplus holders get compensation; current charges are frozen.
📉 Some Universal Plus pre-1992 policies may receive extra compensation.
📈 Settlement addresses legacy liabilities without altering current operations.
🏛️ A Canadian court approved a CAD 213.5 million settlement regarding legacy life insurance policies sold by MetLife agents in Canada.
📅 The class action covers approximately 70,000 current and former policyholders with policies issued between 1985 and 1998.
💰 Eligible Flexiplus policyholders will receive compensation for past cost-of-insurance increases, while charges are to be frozen for current holders.
📉 Certain Universal Plus policyholders issued before 1992 may receive compensation where charges exceeded specified premium limits.
⚖️ Sun Life administers the policies and denied wrongdoing but agreed to the settlement after acquiring Clarica in 2002.
🔍 The case originally involved 230,000 policies with plaintiffs initially seeking CAD 2.5 billion in damages.
💸 MetLife stock traded at 89.78 euros on October 30, 2026, amidst renewed investor attention to legacy liabilities.
📈 The settlement focuses on indemnity arrangements and recovery claims rather than changing current operating business performance.
Risk Factors
CAD 213.5M settlement liability for Canadian legacy policies.
Risk Factors
MetLife faces a CAD 213.5 million settlement liability related to legacy life insurance policies sold by its agents in Canada.
The approved agreement exposes MetLife to potential financial obligations regarding cost-of-insurance charges and administration fees for approximately 70,000 policyholders.
Sun Life, which administers the policies, previously indicated it would seek recovery from MetLife if the settlement is approved, creating a contingent liability risk.
Company updateLegal settlementAI-generated analysis
MetLife (MET) shares are trading near $100 per share after an 82.5% gain over the last five years, prompting analysis of whether current pricing reflects underlying capital returns. The article applies an Excess Returns model to evaluate the insurer's efficiency in converting equity into profits above investor requirements, utilizing a book value of $43.03 and a stable estimate of $51.92 per share.
According to the model, MetLife generates an excess return of $4.54 per share based on a stable EPS of $8.39 and a cost of equity of $3.85, resulting in an average return on equity of 16.16%. This framework suggests the stock's intrinsic value is substantially higher than the current market price of $99.98, despite legal headwinds.
A significant factor influencing valuation is a C$213.5 million settlement approved for universal life policies sold in Canada, which introduces cash flow uncertainties and affects compensation structures. Community narratives suggest MetLife remains 7% undervalued if the company successfully executes its 'New Frontier' program, projecting 10% EPS growth in 2025 and a 17% adjusted ROE by mid-2026.
📈 MetLife shares gained 82.5% over five years, trading near $100.
💰 Book value is $43.03 with a stable estimate of $51.92.
📊 Company generates $4.54 excess return on 16.16% average equity.
⚖️ C$213.5M Canadian settlement creates legal and cash flow uncertainty.
🚀 'New Frontier' program projects 10% EPS growth for 2025.
📈 MetLife shares have gained 82.5% over the past five years, trading close to $100 per share.
💰 The company maintains a book value of $43.03 per share with a stable estimate of $51.92 per share.
📊 MetLife generates an excess return of $4.54 per share based on a 16.16% average return on equity.
⚖️ A C$213.5 million settlement regarding Canadian universal life policies introduces legal and cash flow uncertainties.
🚀 The 'New Frontier' program is associated with projected 10% EPS growth for 2025.
📈 Analyst community narratives currently view MetLife as 7% undervalued based on future profitability patterns.
Bullish Signals
Share price gained 82.5% over five years.
Risk Factors
$213.5M settlement creates legal and cash flow uncertainty.
Ontario class action risks compensation and fee structures.
Bullish Signals
MetLife has delivered an 82.5% share price gain over the last five years, indicating strong long-term shareholder performance.
The Excess Returns model projects MetLife's intrinsic value to be substantially above the current share price of $99.98.
Community narratives suggest MetLife is 7% undervalued if the 'New Frontier' program executes successfully.
The company is projected to achieve 10% EPS growth in 2025 and a 17% adjusted ROE by the first half of 2026.
Risk Factors
A C$213.5 million settlement related to Canadian universal life policies creates legal and cash flow uncertainties that may suppress valuation.
The Ontario class action settlement highlights specific risks regarding compensation paid out and ongoing policy fee structures.
MetLife Inc. (MET) is preparing to release its third-quarter financial results on November 4, 2026, following the close of US markets, with an earnings call scheduled for November 5. The company's stock was trading at EUR 89.95 on October 27, 2026, reflecting a market capitalization of USD 63.6 billion as of late October. This upcoming report is poised to test whether the strong operating trends observed in the second quarter have continued into the third.
MetLife reported adjusted earnings of USD 1.6 billion in the second quarter of 2026, representing a 15% year-over-year increase. Adjusted earnings per share rose 20% to USD 2.43, while GAAP diluted earnings per share increased 6% to USD 1.09. The company demonstrated robust capital returns in the second quarter, distributing more than USD 1.1 billion through repurchases and common stock dividends, alongside an adjusted return on equity of 17.00%.
Analyst sentiment remains positive with several major firms raising their price targets recently. TD Cowen increased its target from USD 110 to USD 114 on October 21, maintaining a Buy rating, while JPMorgan raised its target from USD 108 to USD 110 on October 15. The November results will be critical for investors to assess the sustainability of these earnings beats and the quality of underlying underwriting performance.
📅 MetLife releases Q3 results on November 4, 2026 after US close.
💰 Q2 adjusted earnings rose 15% to USD 1.6 billion year over year.
📈 Adjusted EPS increased 20% to USD 2.43 in the second quarter.
🏦 MetLife returned over USD 1.1 billion to shareholders via buybacks and dividends.
🎯 Analysts raised price targets, with TD Cowen setting a new target of USD 114.
📅 MetLife scheduled its third-quarter results release for November 4, 2026, after the US market close.
💰 The company reported second-quarter adjusted earnings of USD 1.6 billion, up 15% year over year.
📈 Adjusted earnings per share rose 20% to USD 2.43 in the second quarter of 2026.
🏦 MetLife returned more than USD 1.1 billion to shareholders via repurchases and dividends in Q2.
🎯 TD Cowen raised its price target from USD 110 to USD 114 on October 21, 2026.
📊 JPMorgan increased its price target from USD 108 to USD 110 on October 15, 2026.
📉 The stock trades at EUR 89.95 with a market cap of USD 63.6 billion as of late October.
🔍 The upcoming Q3 report will test if the strong second-quarter operating trends have continued.
Bullish Signals
Adjusted earnings rose 15% to USD 1.6B in Q2.
Bullish Signals
MetLife reported adjusted earnings of USD 1.6 billion in the second quarter, marking a 15% year-over-year increase.
Adjusted earnings per share surged 20% to USD 2.43 in the second quarter, significantly outpacing GAAP growth.
The company returned more than USD 1.1 billion to shareholders through repurchases and common stock dividends in Q2.
TD Cowen raised its price target from USD 110 to USD 114 while maintaining a Buy rating on October 21.
JPMorgan increased its price target from USD 108 to USD 110 on October 15, reflecting positive analyst sentiment.
MetLife Inc. is preparing to release its third-quarter 2026 earnings results on November 4, following a strong second quarter where the company reported adjusted earnings of USD 1.6 billion, representing a 15% year-over-year increase. The insurer's performance was bolstered by significant growth in its Group Benefits segment, which generated USD 503 million in adjusted earnings up 25%, and its Asia region, which reached USD 420 million up 21%. Additionally, MetLife Investment Management reported USD 57 million in adjusted earnings, contributing to total assets under management reaching USD 748 billion as of June 30, 2026.
Beyond operational growth, MetLife executed a robust capital return strategy during the second quarter by repurchasing approximately USD 700 million of common shares and announcing a new authorization for up to USD 3 billion in share repurchases. The company also declared a fourth-quarter dividend of USD 0.5925 per share, payable on December 8, 2026, to shareholders of record on November 3. Analyst sentiment remains positive, with JPMorgan raising its price target from USD 108.00 to USD 110.00 while maintaining an overweight rating ahead of the upcoming earnings release.
MetLife's stock is currently trading around EUR 88.45, though it has a primary listing on the NYSE where it quoted at USD 98.82 as of late October 2026. With a market capitalization of approximately USD 62.8 billion and a 52-week range between USD 67.33 and USD 103.65, investors are closely watching the November 4 report to determine if the momentum from the second quarter continues into the third quarter. The upcoming earnings call is scheduled for November 5, 2026.
📈 MetLife Q2 adjusted earnings rose 15% to USD 1.6 billion.
🚀 Group Benefits segment earnings surged 25% to USD 503 million.
💰 MetLife repurchased USD 700M shares and authorized USD 3B more.
🏦 JPMorgan raised price target to USD 110 with overweight rating.
📊 Assets under management reached USD 748 billion as of June 2026.
📈 MetLife reported adjusted earnings of USD 1.6 billion in Q2 2026, a 15% increase year over year.
🚀 Group Benefits segment generated USD 503 million in adjusted earnings, up 25% from the prior year.
🌏 Asia region earnings reached USD 420 million, marking a 21% year-over-year growth.
💰 MetLife repurchased approximately USD 700 million of common shares in the second quarter.
📜 The company announced a new authorization for up to USD 3 billion in share repurchases.
💸 A fourth-quarter dividend of USD 0.5925 per share was declared, payable on December 8, 2026.
🏦 JPMorgan raised its price target from USD 108.00 to USD 110.00 with an overweight rating.
📊 Assets under management reached USD 748 billion as of June 30, 2026.
🗓️ Third-quarter results are scheduled for release on November 4, 2026, after market close.
📞 The earnings call is set to take place on November 5, 2026.
Bullish Signals
Adjusted earnings surged 15% to USD 1.6 billion in Q2 2026.
Group Benefits earnings jumped 25% to USD 503 million.
Asia region earnings grew 21% to reach USD 420 million.
MetLife repurchased USD 700M shares and authorized USD 3B buybacks.
JPMorgan raised price target to USD 110 with overweight rating.
Bullish Signals
MetLife reported adjusted earnings of USD 1.6 billion in the second quarter of 2026, representing a significant 15% year-over-year increase.
The Group Benefits segment generated USD 503 million in adjusted earnings, up 25% from the prior year period.
Asia region earnings reached USD 420 million, showing strong growth of 21% compared to the previous year.
MetLife repurchased approximately USD 700 million of common shares in the second quarter and announced a new USD 3 billion repurchase authorization.
JPMorgan raised its price target from USD 108.00 to USD 110.00 while maintaining an overweight rating on the stock.
Assets under management grew to reach USD 748 billion as of June 30, 2026, indicating strong investment performance.
Adjusted earnings per share rose 20% to USD 2.43, and adjusted return on equity reached 17% in the second quarter.
MetLife Inc. (MET) is a global financial services company with a market capitalization of $46.4 billion, operating in over 40 markets worldwide. The insurer provides life insurance, health and disability benefits, annuities, retirement solutions, and investment management services to individuals, businesses, and institutional clients across the United States, Asia, Latin America, Europe, and the Middle East.
Analysts expect MetLife to report fiscal 2026 third-quarter earnings on November 4 after market close, with a projected diluted profit of $2.71 per share, representing a 15.8% increase from the year-ago quarter. The company has beaten consensus estimates in each of the last four quarters, and full-year analysts expect EPS of $9.94, up 11.8% from fiscal 2025.
MetLife stock has significantly outperformed the broader market over the past 52 weeks, rising 26.4% compared to the S&P 500's 13.1% gains and the Financial Select Sector SPDR ETF's 6.4% returns. Over the last five years, net premiums earned have increased by 2.7% annually while earnings per share grew by 3.3% per year.
On October 6, MetLife declared a fourth-quarter 2026 cash dividend of $0.5925 per common share, payable on December 8, 2026, to shareholders of record as of November 3, 2026. Analyst consensus rates the stock as a Moderate Buy with an average price target of $108.76, indicating potential upside of 10.1% from current levels.
📅 MetLife to report Q3 2026 earnings Nov. 4 after market close.
💰 Analysts project Q3 EPS of $2.71, up 15.8% year-over-year.
🚀 Stock gained 26.4% over past 52 weeks, outperforming S&P 500.
💵 Net premiums earned grew 2.7% annually over last five years.
🏆 Consensus rating is Moderate Buy with $108.76 average price target.
📅 MetLife is expected to announce fiscal 2026 third-quarter earnings on Wednesday, Nov. 4 after the market closes.
💰 Analysts project a diluted profit of $2.71 per share for Q3 2026, up 15.8% from $2.34 in the year-ago quarter.
📈 The company has beaten consensus estimates in each of the last four quarters.
📊 Full-year analysts expect MET to report EPS of $9.94 for fiscal 2026, up 11.8% from fiscal 2025.
🚀 MetLife stock is up 26.4% over the past 52 weeks, outperforming the S&P 500's 13.1% gains.
💵 Net premiums earned increased by 2.7% annually over the past five years for MetLife.
📉 EPS grew by 3.3% per year over the last five years for the insurer.
💸 MetLife declared a Q4 2026 cash dividend of $0.5925 per share on Oct. 6.
📅 The dividend is scheduled to be paid on December 8, 2026, to shareholders of record as of Nov. 3, 2026.
🏆 Analyst consensus rating for MET stock is Moderate Buy with 12 out of 19 analysts advising Strong Buy.
🎯 Average analyst price target is $108.76, indicating potential upside of 10.1% from current levels.
Bullish Signals
Stock outperformed S&P 500 by 13.3 pts over 52 weeks.
Beat consensus estimates for four consecutive quarters.
Achieved 2.7% CAGR in net premiums over five years.
Analysts project 15.8% profit increase to $2.71/share in Q3 2026.
Bullish Signals
MetLife stock has outperformed the S&P 500 Index by 13.3 percentage points over the past 52 weeks, rising 26.4% compared to the index's 13.1% gains.
The company has beaten consensus estimates in each of the last four quarters, demonstrating consistent performance above market expectations.
Over the past five years, MetLife achieved a compound annual growth rate of 2.7% in net premiums earned and 3.3% in earnings per share.
Analysts project a 15.8% year-over-year increase in diluted profit to $2.71 per share for the upcoming fiscal 2026 third quarter.
The board declared a fourth-quarter 2026 cash dividend of $0.5925 per common share, signaling commitment to returning capital to shareholders.
Full-year analysts expect EPS of $9.94 for fiscal 2026, representing an 11.8% increase from the previous year's $8.89.
The average analyst price target of $108.76 suggests a potential upside of 10.1% from current trading levels.
MetLife Inc. reported second-quarter earnings per share of USD 2.43, beating the consensus estimate of USD 2.30. The company also posted quarterly revenue of USD 13.52 billion, representing a 10.50% increase compared to the same quarter in the prior year.
As of October 23, 2026, MetLife stock was trading at USD 102.59 on the NYSE, with a market capitalization of USD 65.2 billion. The stock carries a price-to-earnings ratio of 19.63 and a trailing dividend yield of 2.00 percent.
MetLife is scheduled to release its third-quarter results on November 4, 2026, after the market closes, with an earnings call following on November 5, 2026. The upcoming report will provide investors with fresh data on revenue, earnings, and capital allocation strategies.
The company's valuation metrics place it above peers Prudential Financial and Aflac based on price-to-earnings ratios as of the reporting date.
📈 EPS beat expectations at USD 2.43 in Q2.
💰 Revenue surged 10.50% year-over-year to USD 13.52 billion.
📊 Stock trades at USD 102.59 with a USD 65.2B market cap.
💵 Offers 2.00% trailing dividend yield, ex-date Nov 3, 2026.
📅 Q3 results release scheduled for November 4, 2026.
📈 MetLife posted second-quarter earnings per share of USD 2.43, surpassing analyst expectations of USD 2.30.
MetLife, Inc. (NYSE: MET) reported quarterly earnings of $2.43 per share, beating analyst estimates by $0.13. The company generated revenue of $13.52 billion for the quarter, representing a 10.5% year-over-year increase, though this fell short of the consensus expectation of $19.67 billion. Financial metrics showed a return on equity of 23.39% and a net margin of 4.57%. The stock currently trades with a market capitalization of $65.86 billion and a price-to-earnings ratio of 10.36.
Following the earnings release, MetLife's Board of Directors authorized a new share repurchase program allowing the company to buy back up to $3 billion in shares, which represents approximately 4.8% of its outstanding stock. Additionally, the company declared a quarterly dividend of $0.5925 per share, payable on December 8th to shareholders of record as of November 3rd, offering an annualized yield of 2.3%.
Institutional investor sentiment remains broadly positive, with Cantor Fitzgerald Investment Advisors increasing its stake by 19.5% in the third quarter to own approximately 206,000 shares valued at $19.4 million. Other notable institutional activity includes significant position increases from Robeco Institutional Asset Management B.V., which boosted its holdings by 159.3%, and Nisa Investment Advisors LLC, which raised its position by 1.7%.
Wall Street analysts maintain a consensus 'Moderate Buy' rating on MetLife with an average price target of $105.44. Recent analyst actions include Wells Fargo & Company raising its target price to $110 and TD Cowen increasing its target to $114, while Mizuho lowered its target to $109. The stock has a beta of 0.78 and is trading above its 50-day and 200-day moving averages.
📈 MetLife EPS beat estimates by $0.13 with revenue up 10.5%.
💰 New $3 billion buyback authorized; quarterly dividend set at $0.5925.
🏦 Institutional ownership high at 94.99% as major firms increase stakes.
📊 Analyst consensus 'Moderate Buy' with average price target of $105.44.
💵 Debt-to-equity ratio stands at 0.52 with 45.40% payout ratio.
📈 MetLife reported quarterly EPS of $2.43, beating estimates by $13 cents, with revenue rising 10.5% year-over-year to $13.52 billion.
💰 The company announced a new $3 billion share repurchase authorization and declared a quarterly dividend of $0.5925 per share.
📊 Institutional ownership remains high at 94.99%, with Cantor Fitzgerald increasing its stake by 19.5% to own roughly 206,000 shares.
🏦 Robeco Institutional Asset Management B.V. significantly boosted its position by 159.3%, adding over 135,000 shares to its portfolio.
📈 Analyst consensus is a 'Moderate Buy' with an average price target of $105.44, supported by recent upgrades from TD Cowen and Wells Fargo.
📉 Mizuho lowered its price target to $109, though the stock remains above its 50-day moving average of $97.12.
💵 MetLife maintains a debt-to-equity ratio of 0.52 and a payout ratio of 45.40% on its current dividend.
Bullish Signals
EPS beat estimates at $2.43.
New $3B share repurchase authorized.
Cantor stake increased by 19.5%.
Robeco position expanded 159.3%.
TD Cowen raised target to $114.
Risk Factors
Revenue of $13.52B missed consensus estimate of $19.67B.
Mizho lowered price target from $112.00 to $109.00.
Bullish Signals
MetLife reported quarterly EPS of $2.43, beating analyst estimates by $0.13, demonstrating solid operational performance.
The company secured a new $3 billion share repurchase authorization, signaling management confidence in the stock's valuation and commitment to capital return.
Cantor Fitzgerald Investment Advisors increased its stake by 19.5% in the third quarter, adding 33,557 shares to its holdings.
Robeco Institutional Asset Management B.V. aggressively expanded its position by 159.3%, acquiring an additional 135,186 shares.
TD Cowen raised its price target on MetLife from $110.00 to $114.00 and reaffirmed a 'buy' rating.
Wells Fargo & Company upgraded its outlook with an 'overweight' rating and raised the price target to $110.00.
MetLife declared a quarterly dividend of $0.5925 per share, providing investors with a 2.3% annualized yield.
Risk Factors
MetLife's quarterly revenue of $13.52 billion missed the consensus analyst estimate of $19.67 billion.
Mizuho lowered its price target on MetLife from $112.00 to $109.00, indicating some caution among analysts.
MetLife Inc. reported a strong second quarter in 2026, with adjusted earnings rising 15 percent to USD 1.6 billion and adjusted earnings per share increasing 20 percent year over year to USD 2.43. The company also announced a new authorization for USD 3 billion in share repurchases, signaling confidence in its financial position and commitment to returning capital to shareholders.
Group Benefits emerged as the primary operating driver during this period, posting adjusted earnings of USD 503 million, a 25 percent increase year over year. However, the segment's mortality ratio was 79 percent, which remains below the company's targeted range of 83 percent to 88 percent for 2026, indicating room for improvement in underwriting performance.
Following the earnings release and buyback announcement, MetLife stock reached USD 101.01 on October 13, 2026, after Piper Sandler upgraded the stock to Overweight with a price target increase to USD 110.00. The company is scheduled to report third-quarter results on November 4, 2026, where investors will look for continued underwriting strength to offset potential volatility in investment income.
MetLife has returned over USD 2.4 billion to shareholders through buybacks and dividends as of July 2026. With a market capitalization of approximately USD 63.3 billion, the insurer operates within the Financial Services sector, specifically Life Insurance, and continues to navigate the balance between investment income fluctuations and core underwriting profitability.
📈 Q2 adjusted earnings rose 15% to $1.6B with EPS up 20%.
💰 Authorized new $3B share repurchase program on Oct 9, 2026.
🚀 Piper Sandler upgraded stock to Overweight with $110 price target.
📊 Stock hit $101.01 on Oct 13 following positive earnings news.
💸 Returned over $2.4B to shareholders via buybacks and dividends.
📈 MetLife adjusted earnings rose 15 percent to USD 1.6 billion in Q2 2026, with EPS up 20 percent year over year.
💰 The company authorized a new USD 3 billion share repurchase program on October 9, 2026.
📉 Group Benefits adjusted earnings increased 25 percent to USD 503 million but missed the mortality ratio target of 83-88 percent.
🚀 Piper Sandler upgraded MetLife to Overweight and raised its price target from USD 99.00 to USD 110.00.
📊 Stock reached USD 101.01 on October 13, 2026, following the positive earnings and buyback news.
💸 MetLife has returned over USD 2.4 billion to shareholders via buybacks and dividends through July 2026.
📅 Third-quarter results are scheduled for November 4, 2026, focusing on investment income volatility.
🏢 Market capitalization stands at USD 63.3 billion as of October 19, 2026.
Bullish Signals
Q2 earnings rose 15% to $1.6B with EPS up 20%.
Risk Factors
Group Benefits mortality ratio at 79% vs 83-88% target.
Q3 must offset investment volatility with underwriting gains.
Bullish Signals
MetLife adjusted earnings rose 15 percent to USD 1.6 billion in Q2 2026, with EPS up 20 percent year over year.
The company authorized a new USD 3 billion share repurchase program on October 9, 2026.
Piper Sandler upgraded MetLife to Overweight and raised its price target from USD 99.00 to USD 110.00.
Stock reached USD 101.01 on October 13, 2026, following the positive earnings and buyback news.
MetLife has returned over USD 2.4 billion to shareholders via buybacks and dividends through July 2026.
Risk Factors
Group Benefits mortality ratio was 79 percent, which remains below the company's targeted range of 83 percent to 88 percent for 2026.
The upcoming Q3 report will need to test whether favorable underwriting trends can offset typical investment income volatility.
MetLife Inc. (NYSE: MET) recently experienced a technical breakout as its 50-day moving average crossed above the 200-day average, reversing a death cross that occurred in October. This golden cross is viewed by analysts as a bullish signal indicating a potential stock breakout or upward momentum.
Following this technical shift, MetLife shares have gained more than 5% over the past month, significantly outperforming the S&P 500 which has risen less than 4% in the same period. Despite these positive price movements and a buy recommendation from analysts overall, market sentiment regarding the stock remains weak.
The insurance giant recently reported mixed third-quarter financial results, suggesting that while the technical indicators are favorable, underlying earnings performance has been inconsistent. The company is scheduled to host an investor conference in December, which may provide further clarity on its strategic direction and future outlook.
📈 MetLife stock formed golden cross reversing prior death cross.
📊 Shares climbed over 5% while S&P 500 gained under 4%.
💼 Company posted mixed third-quarter results despite recent gains.
🗓️ Investor conference scheduled for December to discuss strategy.
MetLife's stock recently formed a golden cross as the 50-day moving average crossed above the 200-day average, signaling a potential bullish breakout.
The company's shares have gained more than 5% in the past month, significantly outperforming the S&P 500 which rose less than 4% during the same period.
MetLife Inc. announced on October 6, 2026, that its board declared a fourth-quarter 2026 common-stock dividend of USD 0.5925 per share. This quarterly distribution is scheduled to be payable on December 8, 2026, to shareholders who are on the record as of November 3, 2026.
Following the dividend declaration, MetLife plans to release its third-quarter 2026 financial results on November 4, 2026, after market close. The company will subsequently host an earnings conference call with investors on November 5, 2026, to discuss the quarterly performance and outlook.
Trading data indicates MetLife stock was valued at EUR 89.44 in weekend trading sessions on October 18, 2026, reflecting a bid of EUR 89.18 and an ask of EUR 89.70. These market indications provide current liquidity context for the NYSE-listed insurer as it prepares for its upcoming earnings report.
📅 MetLife declared Q4 2026 dividend of USD 0.5925 per share.
💰 Dividend payable to record holders as of November 3, 2026.
📊 Stock traded at EUR 89.44 on October 18, 2026 weekend.
🗓️ Q3 2026 financial results release scheduled for November 4, 2026.
🎙️ Earnings conference call with investors set for November 5, 2026.
📅 MetLife declared a fourth-quarter 2026 common-stock dividend of USD 0.5925 per share on October 6, 2026.
💰 The quarterly dividend is payable to shareholders of record as of November 3, 2026, with payment scheduled for December 8, 2026.
📊 MetLife stock traded at EUR 89.44 in weekend trading on October 18, 2026, with a bid-ask spread between EUR 89.18 and EUR 89.70.
🗓️ The company will release its third-quarter 2026 financial results on November 4, 2026, following the market close.
🎙️ MetLife is scheduled to hold an earnings conference call with investors on November 5, 2026.
🏢 MetLife Inc. (ISIN US59156R1086) is listed on the NYSE and continues standard weekend trading operations.
Bullish Signals
Declared quarterly dividend of USD 0.5925 per share.
Q3 results due November 4; earnings call Nov 5.
Bullish Signals
MetLife declared a quarterly dividend of USD 0.5925 per share, signaling confidence in its ability to return capital to shareholders.
The company maintains a regular schedule for financial reporting, with Q3 results due on November 4 and an earnings call set for November 5.
MetLife Inc. has declared a fourth-quarter 2026 common stock dividend of USD 0.5925 per share, as announced in an investor release on October 6, 2026. This quarterly distribution represents a direct return of capital to shareholders and signals the company's current liquidity position and confidence in its financial stability ahead of the upcoming fiscal period.
Shareholders of record as of November 3, 2026, will be eligible to receive this dividend payment on December 8, 2026. The declaration coincides with the company's schedule to release its third-quarter financial results and host an earnings conference call on November 4 and November 5, 2026, respectively, providing investors with a comprehensive update on MetLife's operational performance.
The announcement includes specific details regarding the payment date and record date, ensuring clarity for institutional and retail investors planning their portfolios. While the article focuses primarily on these administrative financial events, it confirms that MetLife is proceeding with standard quarterly distributions without any noted interruptions or changes to its capital allocation strategy in this period.
📅 MetLife declared Q4 2026 dividend of USD 0.5925 per share.
💰 Payment scheduled for December 8, 2026 to record holders.
📊 MetLife releases Q3 results and hosts earnings call Nov 4-5.
🏢 Company confirmed regular capital distribution via official investor release.
🕒 Earnings call runs 9:00 a.m. to 10:00 a.m. ET on Nov 5.
📅 MetLife declared a fourth-quarter 2026 common stock dividend of USD 0.5925 per share on October 6, 2026.
💰 The dividend payment is scheduled for December 8, 2026, to shareholders of record as of November 3, 2026.
📊 MetLife is set to release its third-quarter financial results and host an earnings conference call on November 4 and November 5, 2026.
🏢 The company confirmed the dividend amount via an official investor release, maintaining regular capital distribution practices.
🕒 The earnings call is scheduled for 9:00 a.m. to 10:00 a.m. Eastern Time following the market close on November 5.
Bullish Signals
Q4 2026 dividend of USD 0.5925/share shows strong cash flow.
Regular quarterly dividend paid Dec 8, 2026 reflects stability.
Bullish Signals
MetLife declared a fourth-quarter 2026 common stock dividend of USD 0.5925 per share, demonstrating its ability to generate sufficient free cash flow to return capital to shareholders.
The company successfully maintained its regular quarterly dividend schedule, paying out on December 8, 2026, which reflects stable operational performance and liquidity management.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)